Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review.

O'Donnell MJ, Hankey GJ, Eikelboom JW.

Stroke. 2008 May;39(5):1638-46. doi: 10.1161/STROKEAHA.107.497271. Epub 2008 Mar 27. Review. Erratum in: Stroke. 2008 Sep;39(9): e147.

2.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
3.

Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.

Hankey GJ, Eikelboom JW.

Neurology. 2005 Apr 12;64(7):1117-21. Review.

PMID:
15824331
4.

Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.

Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, Shang X, Yan C.

Cerebrovasc Dis. 2015;39(1):13-22. doi: 10.1159/000369778. Epub 2014 Dec 24. Review. Erratum in: Cerebrovasc Dis. 2015;39(3-4):249-51.

5.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

7.
8.

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

Liu F, Tantry US, Gurbel PA.

Expert Opin Pharmacother. 2015 Jun;16(8):1149-65. doi: 10.1517/14656566.2015.1035256. Epub 2015 Apr 14. Review.

PMID:
25873127
9.

Antiplatelet agents and randomized trials.

Diener HC.

Rev Neurol Dis. 2007 Fall;4(4):177-83. Review.

PMID:
18195669
10.

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.

Xie W, Zheng F, Zhong B, Song X.

J Am Heart Assoc. 2015 Aug 24;4(8):e002259. doi: 10.1161/JAHA.115.002259. Review.

11.

Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.

Guthrie R.

Adv Ther. 2011 Jun;28(6):473-82. doi: 10.1007/s12325-011-0026-0. Epub 2011 May 3. Review.

PMID:
21547541
12.

Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.

Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B.

Ann Intern Med. 2013 Oct 1;159(7):463-70. doi: 10.7326/0003-4819-159-7-201310010-00006. Review.

PMID:
24081287
13.

Antiplatelet drugs for ischemic stroke prevention.

Leys D, Balucani C, Cordonnier C.

Cerebrovasc Dis. 2009;27 Suppl 1:120-5. doi: 10.1159/000200449. Epub 2009 Apr 3. Review.

PMID:
19342841
14.

Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.

Coccheri S.

Drugs. 2010 May 7;70(7):887-908. doi: 10.2165/11536000-000000000-00000. Review.

PMID:
20426498
15.
16.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
17.

New insights in antiplatelet therapy for patients with ischemic stroke.

Chaturvedi S, Bhattacharya P.

Neurologist. 2011 Sep;17(5):255-62. doi: 10.1097/NRL.0b013e318224ed70. Review.

PMID:
21881467
18.

Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

Kirshner HS.

Int J Clin Pract. 2007 Oct;61(10):1739-48. Review. Erratum in: Int J Clin Pract. 2007 Nov;61(11):1957.

19.

Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.

Gouya G, Arrich J, Wolzt M, Huber K, Verheugt FW, Gurbel PA, Pirker-Kees A, Siller-Matula JM.

Stroke. 2014 Feb;45(2):492-503. doi: 10.1161/STROKEAHA.113.002590. Epub 2013 Dec 24. Review.

20.

Dual antiplatelet therapy for prevention of recurrent ischemic events.

Nappi J, Talbert R.

Am J Health Syst Pharm. 2002 Sep 15;59(18):1723-35. Review.

PMID:
12298110

Supplemental Content

Support Center